{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:19:04Z","timestamp":1792786744681,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC 98-2314-B-016-031-MY1 & 2"],"award-info":[{"award-number":["NSC 98-2314-B-016-031-MY1 & 2"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC 100-2314-B-016-001"],"award-info":[{"award-number":["NSC 100-2314-B-016-001"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC 102-2314-B-016-027"],"award-info":[{"award-number":["NSC 102-2314-B-016-027"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","award":["MAB101-57"],"award-info":[{"award-number":["MAB101-57"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","award":["103-M082"],"award-info":[{"award-number":["103-M082"]}],"id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taipei Veterans General Hospital, Hsinchu Branch","award":["2017\u2013VHCT-RD-6"],"award-info":[{"award-number":["2017\u2013VHCT-RD-6"]}],"id":[{"id":"https:\/\/ror.org\/03ymy8z76","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Taipei Veterans General Hospital, Hsinchu Branch","award":["2018\u2013VHCT-RD-3"],"award-info":[{"award-number":["2018\u2013VHCT-RD-3"]}],"id":[{"id":"https:\/\/ror.org\/03ymy8z76","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jfma.2018.06.017","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T23:26:45Z","timestamp":1532042805000},"page":"420-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P3","title":["Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation"],"prefix":"10.1016","volume":"118","author":[{"given":"Ching-Long","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chung","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Feng","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Shyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giia-Sheun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jfma.2018.06.017_bib1","first-page":"5","article-title":"The history of valproate in clinical neuroscience","volume":"37","author":"Henry","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jfma.2018.06.017_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jfma.2018.06.017_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jfma.2018.06.017_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4236\/nm.2012.31016","article-title":"Valproic acid, a drug with multiple molecular targets related to its potential neuroprotective action","volume":"3","author":"Ximenes","year":"2012","journal-title":"Neurosci Med"},{"key":"10.1016\/j.jfma.2018.06.017_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jfma.2018.06.017_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jfma.2018.06.017_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.jfma.2018.06.017_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jfma.2018.06.017_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","article-title":"Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia","volume":"134","author":"Peng","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jfma.2018.06.017_bib10","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jfma.2018.06.017_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","article-title":"Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein","volume":"17","author":"Monti","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jfma.2018.06.017_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","article-title":"Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"194","author":"Kidd","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jfma.2018.06.017_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneumeth.2011.06.012","article-title":"Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates","volume":"200","author":"Torres","year":"2011","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jfma.2018.06.017_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroscience.2003.12.017","article-title":"Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain","volume":"124","author":"Ling","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jfma.2018.06.017_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2008.12.004","article-title":"Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging","volume":"216","author":"Ling","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jfma.2018.06.017_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-1-59745-542-8_51","article-title":"Imaging systems for westerns: chemiluminescence vs. infrared detection","volume":"536","author":"Mathews","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jfma.2018.06.017_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jfma.2018.06.017_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jfma.2018.06.017_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jfma.2018.06.017_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jfma.2018.06.017_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.11.026","article-title":"Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions","volume":"169","author":"Truong","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jfma.2018.06.017_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/aps.2011.140","article-title":"Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models","volume":"32","author":"Wang","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jfma.2018.06.017_bib23","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.2174\/1381612811319280009","article-title":"Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery","volume":"19","author":"Fessler","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jfma.2018.06.017_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","article-title":"Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition","volume":"31","author":"Wang","year":"2011","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.jfma.2018.06.017_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/jnp.23.3.jnp242","article-title":"Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research","volume":"23","author":"Lauterbach","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jfma.2018.06.017_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","article-title":"BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra","volume":"350","author":"Hyman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2018.06.017_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.nbd.2008.11.016","article-title":"Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity","volume":"33","author":"Sandhu","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jfma.2018.06.017_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease","volume":"7","author":"Phillips","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jfma.2018.06.017_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfma.2018.06.017_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jfma.2018.06.017_bib31","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","article-title":"Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis","volume":"24","author":"Hao","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jfma.2018.06.017_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.jfma.2018.06.017_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.1992.tb08880.x","article-title":"Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system","volume":"59","author":"Spina","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.jfma.2018.06.017_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.parkreldis.2011.09.002","article-title":"Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease","volume":"18","author":"Liu","year":"2012","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.jfma.2018.06.017_bib35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s11064-008-9848-9","article-title":"Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways","volume":"34","author":"Nguyen","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jfma.2018.06.017_bib36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.cdd.4401662","article-title":"Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways","volume":"12","author":"Almeida","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jfma.2018.06.017_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fitote.2013.07.007","article-title":"The protective activity of imperatorin in cultured neural cells exposed to hypoxia re-oxygenation injury via anti-apoptosis","volume":"90","author":"Wang","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jfma.2018.06.017_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/mol.115.098186","article-title":"Brainstem brain-derived neurotrophic factor signaling is required for histone deacetylase inhibitor-induced pain relief","volume":"87","author":"Tao","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jfma.2018.06.017_bib39","first-page":"820","article-title":"Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction","volume":"6","author":"Lee","year":"2014","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jfma.2018.06.017_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2050-0874-1-4","article-title":"Valproic acid neuroprotection in 6-OHDA lesioned rat, a model for Parkinson's disease","volume":"1","author":"Monti","year":"2012","journal-title":"HOAJ Biol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617306794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617306794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:38:48Z","timestamp":1760539128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664617306794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0929664617306794"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2018.06.017","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2018.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}